(19)

(11)

EP 4 313 273 A1

(12)

(43) Date of publication: 07.02.2024 Bulletin 2024/06 (21) Application number: 22782173.3 (22) Date of filing: 31.03.2022

(51) International Patent Classification (IPC):  A61N 1/36(2006.01) A61N 1/05(2006.01) A61N 1/372(2006.01) (52) Cooperative Patent Classification (CPC): A61N 1/0551; A61N 1/36053; A61N 1/36057; A61N 1/3606; A61N 1/36139; A61N 1/37235; A61N 1/37264; A61B 5/14532 (86) International application number: PCT/US2022/022746 (87) International publication number: WO 2022/212646 (06.10.2022 Gazette 2022/40)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 01.04.2021 US 202163169554 P (71) Applicant: ReShape Lifesciences, Inc. San Clemente, CA 92673 (US)	(72) Inventors: WAATAJA, Jonathan, J. Plymouth, MN 55441 (US) NIHALANI, Raj Irvine, CA 92602 (US) (74) Representative: Gevers Patents  Intellectual Property House Holidaystraat 5 1831 Diegem 1831 Diegem (BE)